New Analyst Forecast: $PSNL Given 'Buy' Rating - Nasdaq
Yesterday • Google News
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
Yesterday • Google News
Yesterday • Google News